Schizophrenia, Cerebellar Ataxia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Schizophrenia, Cerebellar Ataxia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06958341

Neuroimmunology Registry and Biobank

A variety of antineuronal antibodies have been detected in the cerebrospinal fluid (CSF) of patients with neurological diseases. This raises the question of whe…

Germany300 participantsStarted 2021-02-01

All recent trials (2 shown)

TerminatedPhase 1

NCT02566759

A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants

The purpose of this study is to determine the safety, tolerability and pharmacokinetics (PK) of single and multiple rising doses of TAK-831 in healthy participa…

United Kingdom110 participantsStarted 2015-09-23

Treatment: TAK-831 Oral Suspension, TAK-831 Placebo